Cargando…
Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer
SIMPLE SUMMARY: Bladder cancer accounts for a significant burden to global public health. Despite advances in therapeutics with the advent of immunotherapy, only a small subset of patients benefit from immunotherapy. In this review, we examine the evidence that suggests that the TGF-β pathway may pr...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616345/ https://www.ncbi.nlm.nih.gov/pubmed/34830879 http://dx.doi.org/10.3390/cancers13225724 |